OneStream, Inc. delivers an integrated, adaptable software platform, enhanced with artificial intelligence capabilities, to clients across the United States and internationally. Their flagship offering, the Digital Finance Cloud platform, provides essential solutions for modern financial management. These include simplifying financial close and consolidation by automating various tasks and expertly navigating the intricate requirements and standards of financial reporting. The platform also supports comprehensive financial and operational planning, budgeting, forecasting, and detailed results analysis, not only for individual business units but also for harmonizing plans across the entire enterprise. Furthermore, it offers robust financial and operational reporting, ensuring clear, end-to-end visibility of analytics and crucial performance indicators for a diverse audience, including senior executives, finance experts, departmental leaders, and other collaborators. OneStream, Inc. caters to a broad clientele, comprising major corporations, mid-sized organizations, and governmental entities. The company was founded in 2012 and is based in Birmingham, Michigan.
businesswire.comWilliamsMarston's AIT Consulting Services Wins OneStream AI Excellence Awardbusinesswire.comJun 10
gurufocus.comZai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancergurufocus.comJun 8
gurufocus.comCamizestrant Combination Delayed Time to First Progression by 55% and to Second Progression by 37% in Patients With Advanced HR-positive Breast Cancer With an Emergent ESR1 Tumor Mutation in SERENA-6gurufocus.comJun 2
gurufocus.comIDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Line HLA*A2:01 Negative Metastatic Uveal Melanoma in a Lategurufocus.comJun 1
gurufocus.comIvonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONgurufocus.comMay 31